Scaling a SaaS Selling to Skeptical Scientists with Mike Klein, CEO of Genomenon

Dan Balcauski speaks with Mike Klein, CEO of Genomenon, a genomics intelligence company that combines AI, data, and real-world evidence to create a comprehensive knowledge base for precision therapeutics. Mike discusses his journey in scaling Genomenon, the challenges of selling to scientifically-minded customers, and the strategic shift to a freemium model that led to significant adoption. He highlights the complexities of transitioning from a small to a large team, the importance of delegat...